Abstract:Background Conventional risk prediction models for Major Adverse Cardio/Cerebrovascular Events (MACCE) primarily rely on non-modifiable factors such as age, sex, and physiological measurements, including LDL/HDL cholesterol and blood pressure readings, that are prone to variations across medical practices and are often unavailable in many parts of the world. In this study, we investigate the potential of inexpensive wearable measurements of physical activity to enhance MACCE prediction when physiological measurements are unavailable. Purpose To assess the added value of physical activity measurements, collected via wrist-worn accelerometers, to established cardiovascular risk prediction models. Additionally, we seek to investigate whether physical activity measurements can substitute for common physiological measurements in established cardiovascular risk models. Methods We obtained accelerometer-measured physical activity over 7 days between 2013 and 2015 from 69,898 UK Biobank (UKB) participants without a prior history of MACCE, defined as death or hospitalisation due to (1) myocardial infarction, (2) heart failure, or (3) Stroke/transient ischaemic attack. We assessed the added value of daily step counts, sleep duration, and a deep learning-derived activity health score (Fig 1), calculated from complete 7-day accelerometer recordings, to established clinical risk models (SCORE2, QRISK3 and AHA) before and after excluding measurements of cholesterol and systolic blood pressure (SBP). The primary outcome was the first recorded MACCE within 6 years. Risk scores were developed in men and women using Cox proportional hazards models. We assessed predictive performance using Harrel's C-index, net reclassification index (NRI), and net benefit at the recommended treatment threshold for each model. Results Of the 69,898 UKB participants in the study, 3,386 (4.8%) experienced a MACCE over a 6-year follow-up period. In place of HDL ratio and SBP, the addition of deep-learned activity health scores modestly improved performance in the best clinical baseline, QRISK3 for Female participants ΔC-index women:0.003 (95% CI 0.002-0.004); Δnet benefit 0.02(0.01-0.03); NRI 0.04, (0.02-0.07), and outperformed manually extracted steps and sleep measurements. We report no significant improvements for men. We find a greater increase in model performance when both HDL ratio and SBP, plus activity health scores, are included in the model. ΔC-index women:0.008, (0.007-0.009); men: 0.003 (0.002-0.004) (Fig 2). Conclusion Our findings indicate that in the absence of cholesterol and systolic blood pressure, the addition of device-measured physical activity modestly improves the performance of clinical risk scores among individuals without prior cardiovascular disease (CVD). These findings could further refine intervention strategies for targeted prevention of CVD, particularly in settings where physiological measurements may be unavailable.

Evaluating the prediction performance of objective physical activity measures for incident Parkinson’s disease in the UK Biobank

Quantifying the Predictive Performance of Objectively Measured Physical Activity on Mortality in the UK Biobank

Predicting future fallers in Parkinson's disease using kinematic data over a period of 5 years

Association between physical activity and Parkinson’s disease: A prospective cohort study

Daily steps are a predictor of, but perhaps not a modifiable risk factor for Parkinson's Disease: findings from the UK Biobank

Physical Activity and Sleep Pattern in Relation to Incident Parkinson’s Disease: a Cohort Study

Lifetime physical activity influences Parkinson's disease progression

Prediction of individual progression rate in Parkinson's disease using clinical measures and biomechanical measures of gait and postural stability

Prediction of Future Parkinson Disease Using Plasma Proteins Combined with Clinical-Demographic Measures

Multi-predictor modeling for predicting early Parkinson's disease and non-motor symptoms progression

Association of physical activity pattern and risk of Parkinson's disease

The Relative Contribution of Physical and Cognitive Fall Risk Factors in People With Parkinson’s Disease

NHANES 2011-2014: Objective Physical Activity is the Strongest Predictor of All-Cause Mortality

Using a smartwatch and smartphone to assess early Parkinson's disease in the WATCH-PD study over 12 months

Machine learning based risk prediction for Parkinson's disease with nationwide health screening data

Association of Physical Activity and Parkinson Disease in Women: Long-term Follow-up of the E3N Cohort Study

Physical activity and risk of Parkinson's disease: an updated systematic review and meta-analysis

Wearable accelerometer-derived physical activity and incident disease

The added value of device measured physical activity to the prediction of incident cardiovascular disease.

Parkinson’s disease determinants, prediction and gene–environment interactions in the UK Biobank

Simplification of Mobility Tests and Data Processing to Increase Applicability of Wearable Sensors as Diagnostic Tools for Parkinson's Disease